Verastem Oncology (NASDAQ: VSTM) has recently announced positive updated safety and efficacy results from the ramp 205 phase 1/2 trial, which is evaluating avutometinib plus defactinib in combination ...

An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies ...

This revision follows the commencement of a new Olympic Cycle post-Paris Olympics 2024, meeting in mind India’s aspirations ...

Incyte Corp. has disclosed GTPase KRAS (mutant) inhibitors reported to be useful for the treatment of cancer, as well as autoimmune and inflammatory disorders.

Scientists at Jiangsu Hengrui Medicine Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have described GTPase KRAS (G12D mutant) and/or KRAS (G12V mutant) inhibitors reported to be useful for the ...

Eli Lilly and Company today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, ...

To file Nil Returns, all you need is a KRA PIN, access to the iTax portal, and a reliable internet connection.

Thirteen sports in India will soon have league culture, basketball, badminton, archery, boxing, wrestling, white water sports ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute ...